DMAA
Drugs Made In·NASDAQ
--
--(--)
--
--(--)
DMAA Filings
Filing Date
Form Description
Form Type
2025-11-18
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-18 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-18
Form 8-K - Current report
Key Events
2025-11-18 · Key Events
Form 8-K - Current report
2025-11-17
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
2025-11-17 ·
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
2025-11-12
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-08-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-08-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-08-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-08-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-05-20
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-05-20 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-05-15
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-05-15 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-05-15
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
2025-05-15 ·
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
2025-05-15
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-05-15 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
